Cervical Cancer: Add a Dash of Immunotherapy
Despite advances in cancer treatment, cervical cancer, particularly locally advanced disease, remains a challenging entity with a poor prognosis. For patients with persistent, recurrent, or metastatic cervical cancer, pembrolizumab has…
January 15, 2025
